Many highly-successful MBI graduates have made the leap from academia to industry. Nevertheless, the world of biotech and the drug discovery pipeline in particular, can be a mystery. The MBI is working with researchers at Amgen to illuminate the process by which new drugs are developed, tested and brought to market.
This 3-day workshop, lead by Amgen researchers, covers key aspects of the drug discovery process, including:
- Identifying therapeutic targets
- Increasing efficacy and safety
- Process development, devices and manufacturing
- Case studies from bench to clinic
The workshop will culminate with a site-visit to the Amgen campus in Thousand Oaks.
*Due to space limitations, the site-visit will be restricted to those who also attended the on-campus workshops.
2019 Workshop Schedule
|Wednesday 27th March||Noon - 1pm||Boyer Hall 159||Introduction to Drug Discovery and Development at Amgen||John Ferbas, PhD
Director, Cytometry Sciences
|1pm - 2pm||Boyer Hall 159||Bench-to-bedside case study 1: BiTE therapeutics to treat cancer||Paul Hughes, PhD
Scientific Director, Oncology
|2.15-3.15pm||Boyer Hall 159||Bench-to-bedside case study 2: developing treatments for migraine||Cen Xu, PhD
Scientific Director, Neuroscience
|Thursday 28th March||Noon- 1pm||Boyer Hall 159||Bench-to-bedside case study 3: developing treatments for osteoporosis||Chris Paszty, PhD
Scientific Director, Cardiometabolic Disorders
|1pm- 2.30pm||Boyer Hall 159||Exploring careers in Biotech.||Amgen representatives from HR, the Amgen Postdoc Program and Summer Intern Program.|
|Friday 29th March||7.15am - 2pm||Amgen Thousand Oaks||Lab tours and Q&A with current postdocs|